Oragenics Provides Update on SARS-CoV-2 (COVID-19) Program

Why Oragenics Stock Is Trading Higher Today

12:00am, Friday, 10'th Jul 2020
Oragenics (NYSE: OGEN) shares are trading higher on Friday after the company discontinued its AG013 oral mucositis development program and said it will use available cash to...
On Wednesday,  shares of Oragenics, Inc. (AMEX:OGEN) reached at $0.51 price level during last trade its distance from 20 days simple moving average was -9.98%, and its distance from 50 …
On Monday,  shares of Oragenics, Inc. (AMEX:OGEN) reached at $0.53 price level during last trade its distance from 20 days simple moving average was -6.16%, [...]
Oragenics Inc (NYSEAMERICAN:OGEN) was the target of a significant drop in short interest in June. As of June 15th, there was short interest totalling 974,800 shares, a drop of 25.6% from the May 31st
Oragenics Inc (NYSEAMERICAN:OGEN) shares passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.
Oragenics, Inc. to Present at the June 2020 Virtual Summer Investor Summit
NEW YORK, NY / ACCESSWIRE / June 3, 2020 / The Virtual Summer Summit will take place on June 9 th -12 th , connecting 47 presenting small and microcap companies with distinguished investors from aroun
Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
Oragenics Inc. and Aragen Bioscience Enter Agreement to Accelerate Development of TerraCoV2, a SARS-CoV-2 (COVID 19) Vaccine Candidate
By David Bautz, PhD NASDAQ:BCLI READ THE FULL OGEN RESEARCH REPORT Business Update Developing Vaccine Against SARS-CoV-2 On May 4, 2020, Oragenics, Inc. (OGEN) announced the acquisition of Noachis Ter
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE